Atlantic Canada Modified Constraint Induced Movement Therapy Trial

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Stroke
Interventions
BEHAVIORAL

modified constraint induced movement therapy (mCIMT)

The intervention group will receive usual care plus mCIMT. mCIMT consists of two components delivered in parallel: three 30 min therapy sessions/week focusing on progressively more difficult tasks performed with the arm/hand, and five hours/weekday of restraint of the unaffected upper limb. Each 30 min therapy session consists of using the affected upper limb in practicing 4-5 functionally relevant tasks.

OTHER

Usual and Customary Care

Patients in this arm will receive usual care dose-matched to the experimental care group. Usual care will consist of occupational and physiotherapy intervention focused on affected upper limb range of motion (i.e., active range of motion incorporated into functional tasks such as reaching), strengthening (i.e., upper limb resisted exercise), manual dexterity exercises (i.e., grasp and release, stacking cones), and general aerobic conditioning (i.e., recumbent stepper, treadmill).

Trial Locations (1)

B3H 3A7

Capital Health, Halifax

All Listed Sponsors
collaborator

Dalhousie University

OTHER

collaborator

Sunnybrook Research Institute

OTHER

lead

Nova Scotia Health Authority

OTHER

NCT01283620 - Atlantic Canada Modified Constraint Induced Movement Therapy Trial | Biotech Hunter | Biotech Hunter